REQUEST A DEMO
Total
USD $0.00
Search more companies

Zuellig Pharma Korea Co.,Ltd. (South Korea)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Zuellig Pharma Korea Co.,Ltd. Profile Updated: October 27, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

Zuellig Pharma Korea Co., Ltd. is a leading healthcare solutions company located in Seoul. The company was established in the Philippines in 1922 and has since expanded into a dynamic transnational group of companies. Zuellig Pharma's main focus is on increasing accessibility to healthcare in Asia by providing world-class distribution, digital, and commercial services. They offer a suite of services including clinical reach, distribution, digital and channel services, and patient care to support those with chronic conditions. The company operates advanced cold chain facilities for the safe handling of temperature-sensitive medicines and leverages its strong local network in Asia to stay ahead of evolving healthcare needs. Zuellig Pharma is committed to its core values of integrity and trust, collaboration, passion for excellence, innovation, and personal growth. Their mission is to provide accessible healthcare solutions in Asia.

Headquarters
3rd Floor, 92, Hangang-daero Yongsan-gu Seoul
Seoul; Seoul; Postal Code: 140702

Contact Details: Purchase the Zuellig Pharma Korea Co.,Ltd. report to view the information.

Website: http://www.zuelligpharma.com

Basic Information
Total Employees:
Purchase the Zuellig Pharma Korea Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Zuellig Pharma Korea Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Zuellig Pharma Korea Co.,Ltd. report to view the information.
Incorporation Date:
January 15, 1997
Key Executives
Purchase this report to view the information.
Chairman
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Kyungdongsa Co.,Ltd.
Company Performance
Financial values in the chart are available after Zuellig Pharma Korea Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-2.71%
Total operating revenue
-2.71%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
8.59%
Total equity
N/A
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
-20.7%
Debt to Equity Ratio
N/A
Quick Ratio
0.06%
Cash Ratio
0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?